Board Meeting7 Aug 2026, 02:06 pm
Emmessar Biotech Declares Unaudited Q1 FY27 Results
AI Summary
Emmessar Biotech & Nutrition Ltd announced its unaudited financial results for the quarter ended June 30, 2026. The Board of Directors approved these results, which were reviewed by the Audit Committee. A limited review report from statutory auditors M/s. V. Nagarajan & Co. was also provided. The company also announced its 34th Annual General Meeting (AGM) will be held on September 29, 2025, via video conferencing. The cutoff date for remote e-voting is September 22, 2026, with voting commencing on September 26, 2026, and concluding on September 28, 2026.
Key Highlights
- Unaudited financial results for Q1 FY27 declared.
- Board approved results reviewed by Audit Committee.
- Limited review report from statutory auditors enclosed.
- 34th AGM scheduled for September 29, 2025, via video conference.
- Remote e-voting period set from September 26-28, 2026.
Price Impact
More from EMMESSA